Tsai John 4
4 · Blueprint Medicines Corp · Filed Jan 9, 2023
Insider Transaction Report
Form 4
Tsai John
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-01-06+7,950→ 7,950 totalExercise: $46.87Exp: 2033-01-06→ Common Stock (7,950 underlying) - Award
Common Stock
2023-01-06+3,900→ 3,900 total
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of a grant of 3,900 restricted stock units in accordance with the Issuer's non-employee director compensation policy.
- [F2]This option vests with respect to 1/36th of the shares underlying the option on February 6, 2023 and as to an additional 1/36th of the shares underlying the option each month thereafter.